| Line Item | 2023-07-31 | Y/Y |
|---|---|---|
| R&D Expense | $53K | -79.5% |
| SG&A Expense | $14K | -88.4% |
| Operating Income | -$52K | +86.2% |
| Pre-tax Income | -$293K | +23.1% |
| Net Income | -$293K | +23.1% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2023-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1K | -93.3% |
| Current Assets | $1K | -93.4% |
| Total Assets | $1K | -98.4% |
| Current Liabilities | $7K | -98.8% |
| Total Liabilities | $7K | -98.8% |
| Stockholders' Equity | -$5K | +98.9% |
| Line Item | 2023-07-31 | Y/Y |
|---|---|---|
| Financing Cash Flow | -$111K | -133.0% |